In the BioHarmony Drug Report Database

"Preview" Icon

Vestronidase alfa

Mepsevii (vestronidase alfa) is an enzyme pharmaceutical. Vestronidase alfa was first approved as Mepsevii on 2017-11-15. It has been approved in Europe to treat mucopolysaccharidosis VII.

 

Trade Name

 

Mepsevii
 

Common Name

 

vestronidase alfa
 

ChEMBL ID

 

CHEMBL3707382
 

Indication

 

mucopolysaccharidosis vii
 

Drug Class

 

Enzymes; estrogens

Image (chem structure or protein)

Vestronidase alfa structure rendering